Serum GFAP and UCHL1: Evaluation of Their Predictive Value for SAH
NCT06581757 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 144
Last updated 2025-06-15
Summary
To verify the analytical performance of GFAP and UCH-L1 biomarkers marketed by Abbott Diagnostics and to assess diagnostic accuracy of these biomarkers in predicting subarachnoid haemorrhage
Conditions
- Subarachnoid Haemorrhage (SAH)
Sponsors & Collaborators
-
The Royal Wolverhampton Hospitals NHS Trust
lead OTHER_GOV
Principal Investigators
-
Leanne Young · The Royal Wolverhampton NHS Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-16
- Primary Completion
- 2025-04-28
- Completion
- 2025-04-28
Countries
- United Kingdom
Study Locations
More Related Trials
-
Prospective Assessment of the Rockall Risk ScoringSystem in Patients With Upper Gastrointestinal Hemorrhage
NCT02405286 ·Status: COMPLETED
-
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
NCT00482794 ·Status: RECRUITING
-
Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma
NCT01022515 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Prognostic Scores in Patients With Upper Gastrointestinal Bleeding and Cancer
NCT02508883 ·Status: COMPLETED
-
Evaluation of Menses in Congenital Bleeding Disorders
NCT01261936 ·Status: UNKNOWN
-
Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France
NCT02887781 ·Status: RECRUITING
-
Lymphangioleiomyomatosis, a Study on Cathepsin K
NCT05323370 ·Status: COMPLETED
-
Performance Value of Research of Occult Gastrointestinal Bleeding by Immunoassay in the Diagnostic Process of Iron Deficiency Anemia in Patients Over 75 Years
NCT02727075 ·Status: COMPLETED
-
Adult Outcomes of Children With CAPS
NCT04856540 ·Status: COMPLETED
-
UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study
NCT05893316 ·Status: UNKNOWN
-
Hereditary Paraganglioma: Evaluation of Screening Methods to Detect Tumors in SDH Positive Carriers
NCT00188019 ·Status: COMPLETED ·Phase: NA
-
Angelman Syndrome (AS) Biomarker Study
NCT04103333 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Antiphospholipid Syndrome Collaborative Registry (APSCORE)
NCT00076713 ·Status: COMPLETED
-
Altered PSA Test Due to Possible Suspected Heterophilic Antibodies
NCT02455466 ·Status: TERMINATED
-
Hematological Disorders in Patients With GI Angiodysplasia
NCT07183995 ·Status: NOT_YET_RECRUITING
-
Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument
NCT00772434 ·Status: COMPLETED
-
Efficacy and Utility of Cxbladder Tests in Hematuria Patients
NCT04943380 ·Status: COMPLETED
-
APOL1 Genotyping CTA Clinical Performance Study
NCT06839833 ·Status: RECRUITING ·Phase: NA
-
Clinical Outcomes of Primary Versus Secondary Antiphospholipid Syndrome
NCT06808607 ·Status: NOT_YET_RECRUITING
-
Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2
NCT01970735 ·Status: COMPLETED ·Phase: NA
-
Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)
NCT06626386 ·Status: RECRUITING
-
Validation of the RADIAL Algorithm for Diagnosis of Autosomal Recessive Cerebellar Ataxia
NCT04261127 ·Status: RECRUITING ·Phase: NA
-
New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
NCT02250287 ·Status: COMPLETED
-
Podocyturia - Predictor of Renal Dysfunction in Fabry Nephropathy
NCT02994303 ·Status: UNKNOWN
-
Cohort Follow-up of Patients With Renal or Craniocervical Fibromuscular Dysplasia
NCT02961868 ·Status: COMPLETED ·Phase: NA